[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Nuclear Medicine/Radiopharmaceutic Market Report 2018

March 2018 | 114 pages | ID: U5DD471E1C4QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Nuclear Medicine/Radiopharmaceutic market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Nuclear Medicine/Radiopharmaceutic in these regions, from 2013 to 2025 (forecast).
United States Nuclear Medicine/Radiopharmaceutic market competition by top manufacturers/players, with Nuclear Medicine/Radiopharmaceutic sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Company
  • Bracco Imaging
  • Bayer
  • Mallinckrodt
  • Nordion
  • Triad Isotopes
  • Lantheus
  • IBA Group
  • GE Healthcare
  • China Isotope & Radiation
  • Jubilant Pharma
  • Eli Lilly
  • Advanced Accelerator Applications
  • SIEMENS
  • Dongcheng
  • Navidea
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Diagnostic Radioisotopes
  • Therapeutic Radioisotopes
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Oncology
  • Cardiology
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Nuclear Medicine/Radiopharmaceutic Market Report 2018

1 NUCLEAR MEDICINE/RADIOPHARMACEUTIC OVERVIEW

1.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceutic
1.2 Classification of Nuclear Medicine/Radiopharmaceutic by Product Category
  1.2.1 United States Nuclear Medicine/Radiopharmaceutic Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Nuclear Medicine/Radiopharmaceutic Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Diagnostic Radioisotopes
  1.2.4 Therapeutic Radioisotopes
1.3 United States Nuclear Medicine/Radiopharmaceutic Market by Application/End Users
  1.3.1 United States Nuclear Medicine/Radiopharmaceutic Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Oncology
  1.3.3 Cardiology
  1.3.4 Others
1.4 United States Nuclear Medicine/Radiopharmaceutic Market by Region
  1.4.1 United States Nuclear Medicine/Radiopharmaceutic Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Nuclear Medicine/Radiopharmaceutic Status and Prospect (2013-2025)
  1.4.3 Southwest Nuclear Medicine/Radiopharmaceutic Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Nuclear Medicine/Radiopharmaceutic Status and Prospect (2013-2025)
  1.4.5 New England Nuclear Medicine/Radiopharmaceutic Status and Prospect (2013-2025)
  1.4.6 The South Nuclear Medicine/Radiopharmaceutic Status and Prospect (2013-2025)
  1.4.7 The Midwest Nuclear Medicine/Radiopharmaceutic Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Nuclear Medicine/Radiopharmaceutic (2013-2025)
  1.5.1 United States Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2013-2025)
  1.5.2 United States Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2025)

2 UNITED STATES NUCLEAR MEDICINE/RADIOPHARMACEUTIC MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Nuclear Medicine/Radiopharmaceutic Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Nuclear Medicine/Radiopharmaceutic Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Nuclear Medicine/Radiopharmaceutic Average Price by Players/Suppliers (2013-2018)
2.4 United States Nuclear Medicine/Radiopharmaceutic Market Competitive Situation and Trends
  2.4.1 United States Nuclear Medicine/Radiopharmaceutic Market Concentration Rate
  2.4.2 United States Nuclear Medicine/Radiopharmaceutic Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Nuclear Medicine/Radiopharmaceutic Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NUCLEAR MEDICINE/RADIOPHARMACEUTIC SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Region (2013-2018)
3.2 United States Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Region (2013-2018)
3.3 United States Nuclear Medicine/Radiopharmaceutic Price by Region (2013-2018)

4 UNITED STATES NUCLEAR MEDICINE/RADIOPHARMACEUTIC SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Type (2013-2018)
4.3 United States Nuclear Medicine/Radiopharmaceutic Price by Type (2013-2018)
4.4 United States Nuclear Medicine/Radiopharmaceutic Sales Growth Rate by Type (2013-2018)

5 UNITED STATES NUCLEAR MEDICINE/RADIOPHARMACEUTIC SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Application (2013-2018)
5.2 United States Nuclear Medicine/Radiopharmaceutic Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES NUCLEAR MEDICINE/RADIOPHARMACEUTIC PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Company
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Company Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Bracco Imaging
  6.2.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Bayer
  6.3.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Mallinckrodt
  6.4.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Nordion
  6.5.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Nordion Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Triad Isotopes
  6.6.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Triad Isotopes Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Lantheus
  6.7.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Lantheus Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 IBA Group
  6.8.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 IBA Group Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 GE Healthcare
  6.9.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 China Isotope & Radiation
  6.10.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Jubilant Pharma
6.12 Eli Lilly
6.13 Advanced Accelerator Applications
6.14 SIEMENS
6.15 Dongcheng
6.16 Navidea

7 NUCLEAR MEDICINE/RADIOPHARMACEUTIC MANUFACTURING COST ANALYSIS

7.1 Nuclear Medicine/Radiopharmaceutic Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nuclear Medicine/Radiopharmaceutic Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NUCLEAR MEDICINE/RADIOPHARMACEUTIC MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Nuclear Medicine/Radiopharmaceutic Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Nuclear Medicine/Radiopharmaceutic Sales Volume Forecast by Type (2018-2025)
11.3 United States Nuclear Medicine/Radiopharmaceutic Sales Volume Forecast by Application (2018-2025)
11.4 United States Nuclear Medicine/Radiopharmaceutic Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Nuclear Medicine/Radiopharmaceutic
Figure United States Nuclear Medicine/Radiopharmaceutic Market Size (M Dose) by Type (2013-2025)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (Product Category) in 2017
Figure Diagnostic Radioisotopes Product Picture
Figure Therapeutic Radioisotopes Product Picture
Figure United States Nuclear Medicine/Radiopharmaceutic Market Size (M Dose) by Application (2013-2025)
Figure United States Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Application in 2017
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Nuclear Medicine/Radiopharmaceutic Market Size (Million USD) by Region (2013-2025)
Figure The West Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2025)
Figure United States Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Nuclear Medicine/Radiopharmaceutic Market Major Players Product Sales Volume (M Dose) (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceutic Sales (M Dose) of Key Players/Suppliers (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceutic Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Nuclear Medicine/Radiopharmaceutic Sales Share by Players/Suppliers
Figure 2017 United States Nuclear Medicine/Radiopharmaceutic Sales Share by Players/Suppliers
Figure United States Nuclear Medicine/Radiopharmaceutic Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceutic Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Nuclear Medicine/Radiopharmaceutic Revenue Share by Players/Suppliers
Figure 2017 United States Nuclear Medicine/Radiopharmaceutic Revenue Share by Players/Suppliers
Table United States Market Nuclear Medicine/Radiopharmaceutic Average Price (USD/Dose) of Key Players/Suppliers (2013-2018)
Figure United States Market Nuclear Medicine/Radiopharmaceutic Average Price (USD/Dose) of Key Players/Suppliers in 2017
Figure United States Nuclear Medicine/Radiopharmaceutic Market Share of Top 3 Players/Suppliers
Figure United States Nuclear Medicine/Radiopharmaceutic Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Nuclear Medicine/Radiopharmaceutic Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Nuclear Medicine/Radiopharmaceutic Product Category
Table United States Nuclear Medicine/Radiopharmaceutic Sales (M Dose) by Region (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceutic Sales Share by Region (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Share by Region (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region in 2017
Table United States Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceutic Revenue Share by Region (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region in 2017
Table United States Nuclear Medicine/Radiopharmaceutic Price (USD/Dose) by Region (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceutic Sales (M Dose) by Type (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2017
Table United States Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceutic by Type (2013-2018)
Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceutic by Type in 2017
Table United States Nuclear Medicine/Radiopharmaceutic Price (USD/Dose) by Types (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Growth Rate by Type (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceutic Sales (M Dose) by Application (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2017
Table United States Nuclear Medicine/Radiopharmaceutic Sales Growth Rate by Application (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Growth Rate by Application (2013-2018)
Table Company Basic Information List
Table Company Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Company Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure Company Nuclear Medicine/Radiopharmaceutic Sales Market Share in United States (2013-2018)
Figure Company Nuclear Medicine/Radiopharmaceutic Revenue Market Share in United States (2013-2018)
Table Bracco Imaging Basic Information List
Table Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales Market Share in United States (2013-2018)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceutic Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bayer Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure Bayer Nuclear Medicine/Radiopharmaceutic Sales Market Share in United States (2013-2018)
Figure Bayer Nuclear Medicine/Radiopharmaceutic Revenue Market Share in United States (2013-2018)
Table Mallinckrodt Basic Information List
Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales Market Share in United States (2013-2018)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Revenue Market Share in United States (2013-2018)
Table Nordion Basic Information List
Table Nordion Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Nordion Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure Nordion Nuclear Medicine/Radiopharmaceutic Sales Market Share in United States (2013-2018)
Figure Nordion Nuclear Medicine/Radiopharmaceutic Revenue Market Share in United States (2013-2018)
Table Triad Isotopes Basic Information List
Table Triad Isotopes Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Triad Isotopes Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure Triad Isotopes Nuclear Medicine/Radiopharmaceutic Sales Market Share in United States (2013-2018)
Figure Triad Isotopes Nuclear Medicine/Radiopharmaceutic Revenue Market Share in United States (2013-2018)
Table Lantheus Basic Information List
Table Lantheus Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Lantheus Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure Lantheus Nuclear Medicine/Radiopharmaceutic Sales Market Share in United States (2013-2018)
Figure Lantheus Nuclear Medicine/Radiopharmaceutic Revenue Market Share in United States (2013-2018)
Table IBA Group Basic Information List
Table IBA Group Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure IBA Group Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure IBA Group Nuclear Medicine/Radiopharmaceutic Sales Market Share in United States (2013-2018)
Figure IBA Group Nuclear Medicine/Radiopharmaceutic Revenue Market Share in United States (2013-2018)
Table GE Healthcare Basic Information List
Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales Market Share in United States (2013-2018)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Revenue Market Share in United States (2013-2018)
Table China Isotope & Radiation Basic Information List
Table China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales Market Share in United States (2013-2018)
Figure China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Revenue Market Share in United States (2013-2018)
Table Jubilant Pharma Basic Information List
Table Eli Lilly Basic Information List
Table Advanced Accelerator Applications Basic Information List
Table SIEMENS Basic Information List
Table Dongcheng Basic Information List
Table Navidea Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceutic
Figure Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
Figure Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine/Radiopharmaceutic Major Players/Suppliers in 2017
Table Major Buyers of Nuclear Medicine/Radiopharmaceutic
Table Distributors/Traders List
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) and Growth Rate Forecast (2018-2025)
Figure United States Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Nuclear Medicine/Radiopharmaceutic Price (USD/Dose) Trend Forecast (2018-2025)
Table United States Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) Forecast by Type (2018-2025)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) Forecast by Type (2018-2025)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) Forecast by Type in 2025
Table United States Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) Forecast by Application (2018-2025)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) Forecast by Application (2018-2025)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) Forecast by Application in 2025
Table United States Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) Forecast by Region (2018-2025)
Table United States Nuclear Medicine/Radiopharmaceutic Sales Volume Share Forecast by Region (2018-2025)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Volume Share Forecast by Region (2018-2025)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories